חוב לטווח קצר של החברה: codiagnostics.com (CODX)

The decline in post-pandemic demand is forcing Co-Diagnostics, Inc. (CODX) to aggressively optimize expenses, although the absence of loans stabilizes the business. Diversification of diagnostic systems for medicine and veterinary care in Europe and the US reduces risks. The use of contract manufacturing and the external IT sector accelerates the delivery of results. This chart of current short-term loans demonstrates financial stability, where the 0.00 metric determines this level.

To protect capital during periods of volatility, it is critical to assess liabilities with maturities of up to twelve months, which measure the current liquidity and solvency of a business. By analyzing short-term debt with a maturity of up to one year, an investor determines the ability of Co-Diagnostics, Inc. (CODX) to service its debts amid declining revenue from pandemic testing and fierce competition in molecular diagnostics.